SHANGHAI, July 8, 2024 /PRNewswire/ — BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reduction in the 2-SUCCEED trial: a randomized, double-blind, placebo-controlled, dose-ranging phase 2…

IRVINE, Calif., 8 de julio de 2024 /PRNewswire-HISPANIC PR WIRE/ — El icónico Soul de Kia llega para el año modelo 2025 listo para impresionar. El “runabout” urbano continúa con un atractivo MSRP inicial de menos de $21,0001, que incluye una extensa lista de características estándar,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.